FDA OKs Invitrogen genetic test for breast cancer
The U.S. Food and Drug Administration on Tuesday approvedInvitrogen Corp's genetic test for determining whether patientswith breast cancer are good candidates for treatment with the drugHerceptin.
More... |
All times are GMT -7. The time now is 04:03 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021